向细菌细胞壁的药物作为对抗格兰美阳性病原体的工具
Aliaksandr Zhydzetski1, Zuzanna Głowacka-Grzyb1,2, Michal Bukowski1
1Department of Analytical Biochemistry, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Gronostajowa St. 7, 30-348 Cracow, Poland.
Molecules (Basel, Switzerland)
|September 14, 2024
概括
细菌细胞壁是抗生素的关键目标. 新型基于蛋白质的药物,如细菌素和素,对抗多药耐药细菌有前途,为传统抗生素提供了替代品.
科学领域:
- 微生物学 微生物学
- 生物化学 生物化学
- 药物发现 药物发现 药物发现
背景情况:
- 细菌细胞壁对于生存至关重要,也是青素等抗生素的主要点.
- 抗生素耐药性已经出现,导致多药耐药 (MDR) 病原体,迫切需要新型治疗方法.
- 细菌细胞壁的独特组成为安全有效的抗菌剂提供了一个特定的目标.
研究的目的:
- 探索针对细菌细胞壁的蛋白质性药物,作为传统抗生素的替代品.
- 突出细菌素,菌素和细菌素在对抗MDR细菌方面的潜力.
- 引入开发针对特定危险病原体的向治疗的概念.
主要方法:
- 关于蛋白质抗菌剂的现有文献的综述.
- 对细菌素,菌素和细菌素的作用机制的分析.
- 讨论蛋白质化学和药物开发工程方面的进展.
主要成果:
- 像细菌素和 lysins 这样的蛋白质性药物通过向细胞壁来表现出抗菌活性.
- 蛋白质工程使得能够创造出稳定,特异和强大的抗菌药物.
- 通过细胞壁破坏剂选择性向诸如葡萄球菌等病原体是可行的.
结论:
- 基于蛋白质的疗法为克服抗生素耐药性提供了一个有希望的途径.
- 用新型药物准细菌细胞壁提供了特异性和安全性.
- 这些药物的进一步开发对于应对MDR病原体的威胁至关重要.
相关概念视频
Defense Against Bacterial Pathogens
1.4K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K
Antimicrobial Proteins
950
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
950
Targets for Drug Action: Overview
6.1K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.1K
Prokaryotic Cells
34.7K
Prokaryotes are small unicellular organisms that include the domains — Archaea and Bacteria. Bacteria include many common microorganisms, such as Salmonella and E. coli, while the Archaea include extremophiles that live in harsh environments, such as volcanic springs.
Like eukaryotic cells, all prokaryotic cells are surrounded by a plasma membrane, have genetic material in the form of single, circular DNA, a cytoplasm that fills the interior of the cell, and ribosomes that synthesize...
Like eukaryotic cells, all prokaryotic cells are surrounded by a plasma membrane, have genetic material in the form of single, circular DNA, a cytoplasm that fills the interior of the cell, and ribosomes that synthesize...
34.7K
Antibiotic Selection
52.4K
Overview
52.4K
Combined Effects of Drugs: Synergism
3.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.8K


